Clinical utility of the neutrophil distribution pattern obtained using the CELL-DYN SAPPHIRE hematology analyzer for the diagnosis of myelodysplastic syndrome

International Journal of Hematology

Volumn 94, Issue 2, 2011, Pages 169-177

  Inaba, Tohru ^a   Yuki, Yoichi ^a   Yuasa, Soichi ^a   Fujita, Naohisa ^a   Yoshitomi, Kazue ^b   Kamisako, Toshinori ^b   Torii, Kunio ^c   Okada, Toshiharu ^c   Urasaki, Yoshimasa ^c   Ueda, Takanori ^c   Tohyama, Kaoru ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

CELL DYN SAPPHIRE hematology analyzer; Light scatter; Myelodysplastic syndrome (MDS); Neutrophil distribution pattern; Peripheral blood dysgranulopoiesis (PBDG)

Indexed keywords

ADULT; AGED; ARTICLE; AUTOANALYZER; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; GRANULOPOIESIS; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOPENIA; LIGHT SCATTERING; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NEUTROPHIL DISTRIBUTION PATTERN; PERIPHERAL CIRCULATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HEMATOLOGIC TESTS; HUMANS; LIGHT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY; STATISTICAL DISTRIBUTIONS;

EID: 80052380054     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0892-x     Document Type: Article

References (23)

1. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick, et al. 1982 Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 189 199 6952920 1:STN:280:DyaL383gs1GhtQ%3D%3D (Pubitemid 12073508)
2. Brunning RD, Orazi A, Germing U, Le Beau MM, Porwit A, Baumann I, et al. Myelodysplastic syndromes/neoplasms, overview. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 88-93.
3. P Grrenberg C Cox MM Le Beau P Fenaux P Mrel G Sanz, et al. 1997 International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 2079 2088 (Pubitemid 27132124)
4. HJ Olney MM Le Beau 2007 Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes Leuk Res 31 427 434 17161457 10.1016/j.leukres.2006.10.023 1:CAS:528:DC%2BD2sXhs1SksL4%3D (Pubitemid 46198946)
5. P Valent HP Horny JM Bennett C Fonatsch U Germing P Greenberg, et al. 2007 Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference Leuk Res 31 727 736 17257673 10.1016/j.leukres.2006.11.009 (Pubitemid 46855901)
6. P Valent HP Horny 2009 Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions Eur J Clin Invest 39 548 553 19453651 10.1111/j.1365-2362.2009.02151.x 1:STN:280:DC%2BD1MvjsFSjsA%3D%3D
7. B Frisch R Bartl 1992 Minimal diagnostic criteria for the myelodysplastic syndrome (MDS) in clinical practice Leuk Res 16 6 8 1732674 10.1016/0145-2126(92)90093-M 1:STN:280:DyaK387it1yjug%3D%3D
8. A Matsuda I Jinnai F Yagasaki S Kusumoto I Murohashi M Bessho, et al. 1999 New system for assessing the prognosis of refractory anemia patients Leukemia 13 1727 1734 10557045 10.1038/sj.leu.2401556 1:STN:280: DC%2BD3c%2FivVelsg%3D%3D (Pubitemid 29535254)
9. WK Hofmann OG Ottmann A Ganser D Hoelzer 1996 Myelodysplastic syndromes: clinical features Semin Hematol 33 177 185 8819228 1:STN:280: DyaK28vhs1ehtQ%3D%3D (Pubitemid 26247242)
10. G Bourner J Dhaliwal J Sumner 2005 Performance evaluation of the latest fully automated hematology analyzers in a large, commercial laboratory setting: a 4-way, side-by-side study Lab Hematol 11 285 297 16475476 10.1532/LH96.05036 1:STN:280:DC%2BD28%2FovFWitg%3D%3D (Pubitemid 44262556)
11. SH Kang HK Kim CK Ham DS Lee HI Cho 2008 Comparison of four hematology analyzers, CELL-DYN Sapphire, ADVIA 120, Coulter LH 750, and Sysmex XE-2100, in terms of clinical usefulness Int J Lab Hematol 30 480 486 19062362 1:STN:280:DC%2BD1cjptFynsQ%3D%3D
12. Yuki Y, Nishimura H, Saito J, Yamane Y, Nagata T, Yuasa S, et al. Screening of morphological abnormalities in myelodysplastic syndrome using CELL DYNE 3500 hematology analyzer. Jpn J Med Technol. 2009;58:821-6 (abstract in English).
13. R Müller L Mellors B Johannessen AK Aarsand P Kiefer J Hardy, et al. 2006 European multi-center evaluation of the Abott Cell-Dyn sapphire hematology analyzer Lab Hematol 12 15 31 16513543 10.1532/LH96.05041
14. P Hedberg T Lehto 2009 Aging stability of complete blood count and white blood cell differential parameters analyzed by Abbott CELL-DYN Sapphire hematology analyzer Int J Lab Hematol 31 87 96 18190587 10.1111/j.1751-553X. 2007.01009.x 1:STN:280:DC%2BD1M%2FntVakug%3D%3D
15. LW Terstappen BG de Grooth K Visscher FA van Kouterik J Greve 1988 Four-parameter white blood cell differential counting based on light scattering measurements Cytometry 9 39 43 3409785 10.1002/cyto.990090107 1:STN:280:DyaL1czht1SgsQ%3D%3D
16. G d'Onfrio G Zini M Tommasi L Laurenti C Vergine L van Hove 1997 Quantitative bone marrow analysis using the Abbott CELL-DYN hematology analyzer Lab Hematol 3 146 153
17. National Committee for Clinical Laboratory Standards. Reference leukocyte differential count (proportional) and evaluation of instrumental methods: approved standard H20A. Wayne, PA: NCCLS; 1996.
18. MA Stetler-Stevenson D Arthur N Jabbour XY Xie J Molldrem AJ Barrett 2001 Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndromes Blood 98 979 987 11493442 10.1182/blood.V98.4.979 1:CAS:528: DC%2BD3MXmtFeis7k%3D
19. S Cherian J Moore A Bantly JA Vergilio P Klein S Luger, et al. 2005 Flow cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes Am J Hematol 79 243 245 15981222 10.1002/ajh.20371 (Pubitemid 40967083)
20. AA van de Loosdrecht TM Westers AH Westra AM Drager VHJ van der Velden GJ Ossenkoppele 2008 Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry Blood 111 1067 1077 17971483 10.1182/blood-2007-07-098764 (Pubitemid 351213384)
21. S Cherian J Moore A Bantly JA Vergilio P Klein S Luger, et al. 2005 Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes Cytometry B Clin Cytom 64 9 17 15668954 (Pubitemid 40960407)
22. A Miguel M Orero R Simon R Collodo PL Perez A Pacios, et al. 2007 Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia Lab Hematol 13 98 102 17984041 10.1532/LH96.07011 (Pubitemid 351695541)
23. E Haschke-Becher M Vockenhuber P Niedetzky U Totzke C Gabriel 2008 A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome Clin Chem Lab Med 46 85 88 18020973 10.1515/CCLM.2008.012 1:CAS:528:DC%2BD1cXitVWjurc%3D